Me Pharma Sees Opportunities in Low-Cost Strategy, Could Carve Out New Biz Models: President

Me Pharma President Masaru Yoshida While the Japanese generic market continues to grow on the back of the government’s push for its 80% share target, relentless pricing pressure and fierce competition are casting a shadow on the future of the...read more